Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

McKesson/Bristol relationship

Executive Summary

Wholesaler is negotiating with Bristol-Myers Squibb "discussing whether or not" an inventory management agreement "may work for us and for them," McKesson Supply Solutions President Paul Julian says during fiscal Q4 call April 29. The two companies currently are not operating under an IMA. Cardinal CEO Robert Walter has said the wholesaler believes BMS' new inventory management program undervalues Cardinal's current services (1"The Pink Sheet" April 28, p. 15)...

You may also be interested in...



Cardinal Wants New Deal With Bristol; Inventory Practices Reduce Rx Growth

Cardinal is renegotiating its arrangement with Bristol-Myers Squibb because the wholesaler feels the current deal undervalues its services

Long Hot Summer For Novel Drug Reviews Forecast At US FDA

Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.

Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza

The latest drug development news and highlights from our US FDA Performance Tracker.

UsernamePublicRestriction

Register

PS041740

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel